Lackner Mark
SEC insider (Form 3/4/5 filer). CIK 0001777413. Chief Scientific Officer at Zentalis Pharmaceuticals, Inc. (ZNTL). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2025. Located in SAN DIEGO, CA.
Companies Lackner Mark has filed insider reports for
- Zentalis Pharmaceuticals, Inc. (ZNTL): Officer, Chief Scientific Officer
Lackner Mark
CIK: 0001777413
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZNTL
Zentalis Pharmaceuticals, Inc.
Officer